Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥13 | CN¥12 | CN¥11 | CN¥10 |
| - Cash | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| + Debt | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Enterprise Value | CN¥13 | CN¥12 | CN¥11 | CN¥10 |
| Revenue | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Growth | -5.4% | 1.4% | -2.8% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 58% | 47.4% | 45.3% | 51.3% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 23.6% | 21.9% | 13.2% | 6.6% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 9.2% | 9.2% | 3.6% | 2.4% |
| EPS Diluted | 0.073 | 0.078 | 0.03 | 0.021 |
| % Growth | -5.4% | 158.3% | 45.6% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | CN¥0 | CN¥0 | CN¥0 |